Patent
A formulation comprising an ingestible carrier and an isolated strain of Bifidobacterium longum.
1. A formulation comprising an ingestable carrier comprising a stabilizing excipient having a water content of less than about 10% and an isolated strain of Bifidobacterium longum AH1172 having NCIMB accession number 41714.
2. The formulation of claim 1 wherein the ingestable carrier is a pharmaceutically acceptable carrier.
3. The formulation of claim 1 wherein the carrier does not occur in nature.
4. The formulation of claim 1 wherein the formulation is in a form selected from the group consisting of a capsule, a tablet, a pellet, a powder, or combinations thereof.
5. The formulation of claim 1 wherein the strain is present in the formulation at more than 10 6 cfu per gram of the ingestable carrier.